Scientists then isolated it and created a synthetic version to explore its benefits
Appetite suppression is strong, and many individuals need to consciously ensure they meet minimum caloric and nutrient requirements
Retatrutide administered once weekly subcutaneously for 12 weeks resulted in a dose-dependent placebo-adjusted weight loss of up to 8.96 kg in the highest dose group and a placebo-adjusted HbA1c reduction of up to 1.6% in a phase II trial in individuals with T2DM [125]
Skylynn et al., Benefits and Risks of Medications Used in the Management of Hypotension: A Review, Cureus, vol
Sharika R, Mongkolpobsin K, Rangsinth P, Prasanth MI, Nilkhet S, Pradniwat P, et al
Alzheimers disease is type 3 diabetes-evidence reviewed